Effects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosis

Journal of Bone and Mineral Metabolism

Volumn 28, Issue 5, 2010, Pages 561-567

  Takada, Junichi ^a,b   Miki, Takami ^c   Imanishi, Yasuo ^d   Nakatsuka, Kiyoshi ^e   Wada, Hiroshi ^f   Naka, Hiroshi ^c   Yoshizaki, Takashi ^b   Iba, Kousuke ^a   Beck, Thomas J ^g   Yamashita, Toshihiko ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b Kitago Orthopedic Clinic   (Japan)

^c Osaka Prefecture University   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Nozaki Clinic   (Japan)

^f Wada Obstetrics and Gynecology Clinic   (Japan)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone strength; Geometry; Hip fracture; Hip structure analysis; Raloxifene

Indexed keywords

RALOXIFENE;

ADULT; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE STRUCTURE; ELASTICITY; FEMALE; FEMUR; FEMUR NECK; FEMUR SHAFT; GEOMETRY; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL;

ABSORPTIOMETRY, PHOTON; ASIAN CONTINENTAL ANCESTRY GROUP; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMALE; FEMUR; HIP; HUMANS; OSTEOPOROSIS; POSTMENOPAUSE; RALOXIFENE;

EID: 77956925136     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-010-0164-5     Document Type: Article

References (30)

1. JA Kanis 2002 Diagnosis of osteoporosis and assessment of fracture risk Lancet 359 1929 1936 10.1016/S0140-6736(02)08761-5 12057569 (Pubitemid 34615775)
2. PD Miller 2003 Bone mass measurements Clin Geriatr Med 19 281 297 10.1016/S0749-0690(03)00002-8 12916287 (Pubitemid 36514520)
3. AM Schott C Cormier D Hans F Favier E Hausherr P Dargent-Molina PD Delmas C Ribot JL Sebert G Breart PJ Meunier EPIDOS Group 1998 How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS prospective study Osteoporos Int 8 247 254 10.1007/s001980050061 9797909 1:STN:280:DyaK1M%2FhsVKnsQ%3D%3D (Pubitemid 28427074)
4. Z Li MP Meredith MS Hoseyni 2001 A method to assess the proportion of treatment effect explained by a surrogate endpoint Stat Med 20 3175 3188 10.1002/sim.984 11746311 1:STN:280:DC%2BD3MnpvVyktg%3D%3D (Pubitemid 33034879)
5. SR Cummings DB Karpf F Harris HK Genant K Ensrud AZ LaCroix M Dennis DM Black 2002 Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs Am J Med 112 281 289 10.1016/S0002-9343(01)01124-X 11893367 1:CAS:528:DC%2BD38XhvVWkurk%3D (Pubitemid 34219441)
6. S Sarkar BH Mitlak M Wong JL Stock DM Black KD Harper 2002 Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy J Bone Miner Res 17 1 10 10.1359/jbmr.2002.17.1.1 11771654 1:CAS:528:DC%2BD38XktFyisg%3D%3D
7. TJ Beck CB Ruff KE Warden WW Scott Jr GU Rao 1990 Predicting femoral neck strength from bone mineral data: a structural approach Investig Radiol 25 6 18 10.1097/00004424-199001000-00004 1:STN:280:DyaK3c7ivFKktA%3D%3D (Pubitemid 20040519)
8. TJ Beck CB Ruff WW Scott Jr CC Plato JD Tobin CA Quan 1992 Sex differences in geometry of the femoral neck with aging: a structural analysis of bone mineral data Calcif Tissue Int 50 24 29 10.1007/BF00297293 1739866 1:STN:280:DyaK387lsVCqtg%3D%3D
9. TJ Beck CB Ruff K Bissessur 1993 Age-related changes in female femoral neck geometry: implications for bone strength Calcif Tissue Int 53 S41 S46 10.1007/BF01673401 8275379
10. TJ Beck AC Looker CB Ruff 2000 Structural trends in the aging femoral neck and proximal shaft: analysis of the third national health and nutrition examination survey dual-energy X-ray absorptiometry data J Bone Miner Res 15 2297 2304 10.1359/jbmr.2000.15.12.2297 11127194 1:STN:280: DC%2BD3M%2FpsF2mtA%3D%3D
11. XF Wang Y Duan TJ Beck E Seeman 2005 Varying contributions of growth and ageing to racial and sex differences in femoral neck structure and strength in old age Bone 36 978 986 10.1016/j.bone.2004.11.015 15869919 (Pubitemid 40797998)
12. K Uusi-Rasi TJ Beck LM Semanick MM Daphtary GG Crans D Desaiah KD Harper 2006 Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial Osteoporos Int 17 575 586 10.1007/s00198-005-0028-3 16392026 1:CAS:528:DC%2BD28XislCrt70%3D
13. SL Greenspan TJ Beck NM Resnick R Bhattacharya RA Parker 2005 Effect of hormone replacement, alendronate, or combination therapy on hip structure geometry: a 3-year, double blind, placebo-controlled clinical trial J Bone Miner Res 20 1525 1532 10.1359/JBMR.050508 16059624 1:CAS:528:DC%2BD2MXhtVOltrrK (Pubitemid 41243541)
14. K Uusi-Rasi LM Semanick JR Zanchetta CE Bogado EF Eriksen M Sato TJ Beck 2005 Effects of teriparatide [rh PTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women Bone 36 948 958 10.1016/j.bone.2005.03.003 15878318 1:CAS:528:DC%2BD2MXltFSlt7Y%3D (Pubitemid 40797995)
15. SL Bonnick TJ Beck F Cosman MC Hochberg H Wang AE de Papp 2009 DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass Osteoporos Int 20 911 921 10.1007/s00198-008-0762-4 18830555 1:CAS:528:DC%2BD1MXls12kt70%3D
16. TJ Beck EM Lewiecki PD Miller D Felsenberg Y Liu B Ding C Libanati 2008 Effects of denosumab on the geometry of the proximal femur in postmenopausal women in comparison with alendronate J Clin Densitom 11 351 359 10.1016/j.jocd.2008.04.001 18495508
17. J Takada TJ Beck K Iba T Yamashita 2007 Structural trends in the aging proximal femur in Japanese postmenopausal women Bone 41 97 102 10.1016/j.bone.2007.04.178 17513185 (Pubitemid 46891904)
18. Osteoporosis diagnostic criteria review committee: Japanese society for bone, mineral research 2001 Diagnostic criteria for primary osteoporosis: year 2000 revision J Bone Miner Metab 19 331 337 10.1007/s007740170001 (Pubitemid 33041725)
19. D Hans F Duboeuf AM Schott S Horn LV Avioli MK Drezner PJ Meunier 1997 Effects of a new positioner on the precision of hip bone mineral density measurements J Bone Miner Res 12 1289 1294 10.1359/jbmr.1997.12.8.1289 9258760 1:STN:280:DyaK2svgtleqsw%3D%3D (Pubitemid 27334976)
20. CB Ruff WC Hayes 1983 Cross-sectional geometry of Pecos Pueblo femora and tibiae-a biomechanical investigation. I. Method and general patterns of variation Am J Phys Anthropol 60 359 381 10.1002/ajpa.1330600308 6846510 1:STN:280:DyaL3s3gtFGisQ%3D%3D
21. LJ Melton III TJ Beck S Amin S Khosla SJ Achenbach AL Oberg BL Riggs 2005 Contributions of bone density and structure to fracture risk assessment in men and women Osteoporos Int 16 460 467 10.1007/s00198-004-1820-1 15688123
22. Z Chen TJ Beck JA Cauley CE Lewis A LaCroix T Bassford G Wu D Sherrill S Going 2008 Hormone therapy improves femur geometry among ethnically diverse postmenopausal participants in the Women's Health Initiative hormone intervention trials J Bone Miner Res 23 1935 1945 10.1359/jbmr.080707 18665788 1:CAS:528:DC%2BD1MXosVylsbg%3D
23. B Ettinger DM Black BH Mitlak RK Knickerbocker T Nickelsen HK Genant C Christiansen PD Delmas JR Zanchetta J Stakkestad CC Glüer K Krueger FJ Cohen S Eckert KE Ensrud LV Avioli P Lips SR Cummings Multiple Outcomes of Raloxifene Evaluation Investigators 1999 Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial JAMA 282 637 645 10.1001/jama.282.7.637 10517716 1:CAS:528:DyaK1MXlvVKqurg%3D (Pubitemid 29384151)
24. PD Delmas HK Genant GG Crans JL Stock M Wong E Siris JD Adachi 2003 Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial Bone 33 522 532 10.1016/S8756-3282(03)00241-2 14555255 1:STN:280:DC%2BD3svnslSgsw%3D%3D (Pubitemid 37222378)
25. DM Black SR Cummings DB Karpf JA Cauley DE Thompson MC Nevitt DC Bauer HK Genant WL Haskell R Marcus SM Ott JC Torner SA Quandt TF Reiss KE Ensrud Fracture Intervention Trial Research Group 1996 Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures Lancet 348 1535 1541 10.1016/S0140-6736(96)07088-2 8950879 1:CAS:528: DyaK2sXisFCktQ%3D%3D (Pubitemid 26411651)
26. MR McClung P Geusens PD Miller H Zippel WG Bensen C Roux S Adami I Fogelman T Diamond R Eastell PJ Meunier RD Wasnich M Greenwald JM Kaufman CH Chesnut JY Reginster 2001 Effect of risedronate on the risk of hip fracture in elderly women N Engl J Med 344 333 340 10.1056/NEJM200102013440503 11172164 1:CAS:528:DC%2BD3MXht1Wlu7g%3D (Pubitemid 32107641)
27. Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial JAMA 288 321 333 10.1001/jama.288.3.321
28. The Women's Health Initiative Steering Committee 2004 Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial JAMA 291 1701 1712 10.1001/jama.291.14.1701 (Pubitemid 38489892)
29. T Nakamura JL Liu H Morii QR Huang HM Zhu Y Qu E Hamaya D Thiebaud 2006 Effects of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis J Bone Miner Metab 24 414 418 10.1007/s00774-006-0702-3 16937275 1:CAS:528:DC%2BD28Xoslequ7Y%3D (Pubitemid 44306179)
30. SM Cadarette JN Katz MA Brookhart T Stümer MR Stedman DH Solomon 2008 Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture Ann Intern Med 148 637 646 18458276